Baltimore City Council
File #: 20-0228R    Version: 0 Name: Request for State Action - Override Veto on Senate Bill 669 - Prescription Drug Affordability Board and Fund
Type: City Council Resolution Status: Adopted
File created: 5/18/2020 In control: City Council
On agenda: Final action: 5/18/2020
Enactment #:
Title: Request for State Action - Override Veto on Senate Bill 669 - Prescription Drug Affordability Board and Fund For the purpose of calling on the Maryland General Assembly to override the Governor’s veto and pass Senate Bill 669 - Prescription Drug Affordability Board and Fund - as passage of this bill ensures access to affordable prescription drugs.
Sponsors: Edward Reisinger, Mayor Brandon M. Scott, Mary Pat Clarke, Bill Henry, John T. Bullock, Shannon Sneed, Kristerfer Burnett, Leon F. Pinkett, III, Ryan Dorsey, Sharon Green Middleton, Zeke Cohen, Robert Stokes, Sr., Isaac "Yitzy" Schleifer
Indexes: Affordability, Fund, Prescription Drug, Request for State Action, Vetoes
Attachments: 1. 20-0228R~1st Reader

                     Introductory*

 

                     City of Baltimore

                     Council Bill                R

                     (Resolution)

                                                                                                                                                           

Introduced by: Councilmember Reisinger, President Scott

                                                                                                                                                           

 

                     A Resolution Entitled

 

A Council Resolution concerning

title

Request for State Action - Override Veto on Senate Bill 669 - Prescription Drug Affordability Board and Fund

For the purpose of calling on the Maryland General Assembly to override the Governor’s veto and pass Senate Bill 669 - Prescription Drug Affordability Board and Fund - as passage of this bill ensures access to affordable prescription drugs.

body

                     Recitals

 

Whereas, The Prescription Drug Affordability Board is mandated to examine prescription drug costs and affordability in the state, make prescription drugs more affordable for state and local government entities, and present a plan to the General Assembly describing how to make expensive drugs more affordable for all Marylanders;

 

Whereas, Senate Bill 669 levies a fee on pharmaceutical corporations, pharmacy benefits managers, and insurers to provide funding for the Prescription Drug Affordability Board;

 

Whereas, Marylanders across the state are struggling to afford the prescription drugs they need, often having to choose between their medication and other necessities, like rent and groceries;

 

Whereas, COVID-19 has demonstrated the devastating impacts that health disparities have on Baltimore City residents and the importance of affordable healthcare, including affordable prescription drugs;

 

Whereas, Senate Bill 669 - Prescription Drug Affordability Board and Fund - passed the House of Delegates, with a vote of 97-37, and the Senate unanimously, with a vote of 45-0; and

 

Whereas, The Governor vetoed the bill on May 7, 2020.

 

Now, therefore, be it resolved by the City Council of Baltimore, That the City Council calls on the Maryland General Assembly to override the Governor’s veto and pass Senate Bill 669 - Prescription Drug Affordability Board and Fund - as passage of this bill ensures access to affordable prescription drugs.

                     

 

 

And be it further resolved, That a copy of this Resolution be sent to the Honorable Chairs and Members of the Baltimore City House and Senate Delegations to the Maryland General Assembly and the Mayor’s Legislative Liaison to the City Council.